Tirofiban Plus Sirolimus-Eluting Stent May Offer Better Outcome After Acute STEMI Than Bare-Metal Stent Plus Abciximab

The investigators in a randomized trial suggest that tirofiban-supported sirolimus-eluting stenting of infarcted arteries may improve outcomes and limit healthcare costs. (CME)Desiree Lie,Laurie Barclay,Gary Vogin

Continue to Tirofiban Plus Sirolimus-Eluting Stent May Offer Better Outcome After Acute STEMI Than Bare-Metal Stent Plus Abciximab on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz